Candel Therapeutics Stock Quote CADL - Stock Price, News, Charts, Message Board, Trades

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Candel Therapeutics Inc (CADL) Quote

Candel Therapeutics Inc (CADL)

5.99

0.07

(1.18%)

Closed July 10 4:00PM

Delayed by 15 minutes

5.99

0.00

( 0.00% )

Pre Market: 8:43AM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

5.99

Bid

6.10

Ask

6.20

Volume

253

0.00 Day's Range 0.00

0.66 52 Week Range 14.33

Market Cap

Previous Close

5.99

Open

-

Last Trade

Last Trade Time

08:41:58

Financial Volume

-

VWAP

-

Average Volume (3m)

763,117

Shares Outstanding

29,744,731

Dividend Yield

-

PE Ratio

-4.70

Earnings Per Share (EPS)

-1.28

Revenue

-

Net Profit

-37.94M

Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies. Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.candeltx.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Candel Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CADL. The last closing price for Candel Therapeutics was $5.99. Over the last year, Candel Therapeutics shares have traded in a share price range of $ 0.66 to $ 14.33.

Candel Therapeutics currently has 29,744,731 shares outstanding. The market capitalization of Candel Therapeutics is $178.17 million. Candel Therapeutics has a price to earnings ratio (PE ratio) of -4.70.

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Candel Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

NEEDHAM, Mass., June 18, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal...

Candel Therapeutics to Join Russell 3000® Index

NEEDHAM, Mass., June 11, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal...

Form ARS - Annual Report to Security Holders

Form DEF 14A - Other definitive proxy statements

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.27	-4.31309904153	6.26	6.43	5.62	348126	5.88595315	CS
4	-1.65	-21.5968586387	7.64	7.92	5.52	413175	6.18356571	CS
12	0.65	12.1722846442	5.34	14.33	5.05	763117	8.39221815	CS
26	4.63	340.441176471	1.36	14.33	1.16	3017674	6.7481686	CS
52	4.79	399.166666667	1.2	14.33	0.66	1623578	6.23916309	CS
156	-2.01	-25.125	8	14.78	0.66	580598	6.21725372	CS
260	-2.01	-25.125	8	14.78	0.66	580598	6.21725372	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.41 (98.28%)	17.43M
VLCNVolcon Inc	$ 6.54 (79.18%)	9.82M
RNLXRenalytix PLC	$ 0.4777 (58.23%)	39.65M
HSCSHeart Test Laboratories Inc	$ 6.76 (52.94%)	302.17k
BSFCBlue Star Foods Corporation	$ 2.53 (50.60%)	15.13M
IVPInspire Veterinary Partners Inc	$ 5.3887 (-27.18%)	284.32k
SLRXSalarius Pharmaceuticals Inc	$ 2.15 (-21.60%)	1.52M
AGBAAGBA Group Holding Ltd	$ 2.04 (-21.54%)	610.11k
OABIOmniAb Inc	$ 3.27 (-20.82%)	8
HUBCWHub Cyber Security Ltd	$ 0.019 (-19.83%)	100
KZIAKazia Therapeutics Ltd	$ 1.00 (49.66%)	43.17M
RNLXRenalytix PLC	$ 0.4777 (58.23%)	39.65M
MAXNMaxeon Solar Technologies Ltd	$ 0.1945 (-7.73%)	26.3M
PRSTPresto Technologies Inc	$ 0.0775 (0.65%)	18.34M
BDRXBiodexa Pharmaceuticals PLC	$ 1.41 (98.28%)	17.43M

PonkenPlonken

PonkenPlonken 7 days ago

Remember them buying up 450k shares a second after the readout was released on May23 all the way into high 16s.
sooner or later, the data will speak again and everyone will have to listen to whats being said.

Monksdream

Monksdream 7 days ago

falcon21

falcon21 1 month ago

added at 7.50 today

falcon21

falcon21 2 months ago

only 1.5 mil short

glenn1919

glenn1919 2 months ago

CADL................................a/h...................$$$$$$$$$$$$$$$$$$$$$$$$$$$

Monksdream

Monksdream 2 months ago

CADL under $10
Months

skidoo31

skidoo31 3 months ago

Short squeeze coming soon, mm have been borrowing my shares.

PonkenPlonken

PonkenPlonken 3 months ago

agree. mcap should be 1bln $+++.
institutions are waiting on the bid- then do the lifting on liquidity event.

LOTS of retail antihero-themed traders are short. Weak line of defense.

Roadtojourney

Roadtojourney 3 months ago

I cant believe this is still sitting at 5. The orphan designation for pancreatic itself is huge. Makes no sense. Imo

PonkenPlonken

PonkenPlonken 3 months ago

$CADL GROUNDBREAKING data... never before.
see latest presentation regarding pending data in nsclc and CRC
Check Paul Peter Tak vita... Its a home run

skidoo31

skidoo31 3 months ago

Good job, she’s got legs. Maybe it will cool off in the morning for another possible dip then it’s chart making time. Shorts are staying away from this one as the potential for blue sky breakout is very good.

Namaste Charting

Namaste Charting 3 months ago

$cadl. The next few hours should be engaging to say the least

Actualfactual

Actualfactual 3 months ago

Looking for a push towards previous double top of 11.30’s and then a breakout through to blue skies

Namaste Charting

Namaste Charting 3 months ago

Sure is! Added some $cadl $6.50's here

She's got that look!

skidoo31

skidoo31 3 months ago

https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-receives-fda-orphan-drug-designation-can

skidoo31

skidoo31 3 months ago

Chart is building nicely ..

Awl416

Awl416 3 months ago

Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer

philaya

philaya 3 months ago

Short interest 0.89%...
Bears smarter than some.

philaya

philaya 3 months ago

Will buy...
Any time low good.

Roadtojourney

Roadtojourney 3 months ago

Thats it just goes up news and then sell on news?? There is no holding here??

skidoo31

skidoo31 3 months ago

Could be a blue sky breakout if all these fundamentals line up. Big potential here.

skidoo31

skidoo31 3 months ago

New here, do you have a link please? Thank you

stoxjock

stoxjock 3 months ago

I am Getting Ready for tomorrow's Blast-off Opening at $15+, as we could possibly see news at 8:30AM about a 'Private Placement' of maybe 5M Common shares 'Unit's @$15.00/share Plus each Warrant in the unit exercisable at $15/common share, upon dosing of the 1st Patient in the Phase 3 trial...with total 'Net proceeds' of around $140M giving Runway to EOY 2026!

stoxjock

stoxjock 3 months ago

This stock was 'walked down' in PPS Friday afternoon. I am fully loaded. This is going to move up north of $30+ next two months. It has catalyst "READOUTs' coming up next two months and then into 4rth Q. Do not sell out for peanuts profits if you want to make massive gains, just HODL it till EOY 2024.Also, very possible it could be taken out anytime...GLTA!

philaya

philaya 3 months ago

Fund easy...
With the positive meds.

Roadtojourney

Roadtojourney 3 months ago

All that volume and only up 3% lol??

philaya

philaya 3 months ago

fomo monday...
fun to watch.

philaya

philaya 3 months ago

friday selling...
nothing matter.

Monksdream

Monksdream 3 months ago

philaya

philaya 3 months ago

buy the dip...
got some.

Awl416

Awl416 3 months ago

Awl416

Awl416 3 months ago

Invest-in-America

Invest-in-America 3 months ago

CADL: See latest 'CHART', below!!!!

Awl416

Awl416 3 months ago

This action is entertaining

axelvento

axelvento 3 months ago

ALERT- Cash Position: Cash and cash equivalents as of December 31, 2023 were $35.4 million, as compared to $70.1 million as of December 31, 2022. Based on current plans and assumptions, the Company expects that its existing cash and cash equivalents will be sufficient to fund its current operating plan into the fourth quarter of 2024

axelvento

axelvento 3 months ago

Phase 2 topline data for CAN-2409 in low-to-intermediate-risk, localized, non-metastatic prostate cancer expected in Q4 2024
Phase 3 topline data for CAN-2409 in localized intermediate/high-risk prostate cancer expected in Q4 2024

trader59

trader59 3 months ago

The dump here when the computers doing the trading are turned off is going to be brutal.

TIMGZ

TIMGZ 3 months ago

you are very good at taking risk, that is why u are so rich. what about if it dips at 4a.
did you catch it early?

2020trader

2020trader 3 months ago

expecting lower

Invest-in-America

Invest-in-America 3 months ago

CADL: Easiest money of the week, that's for sure, Capt. Tim!!! (And I'm still holding it all.)

TIMGZ

TIMGZ 3 months ago

nice try****so far almost 500%*****

da_stock_analyst

da_stock_analyst 3 months ago

#CADL 🔥 insane run today! What about tomorrow? $cadl

Monksdream

Monksdream 3 months ago

You mean like when I bought GDDY

dinogreeves

dinogreeves 3 months ago

Very true Monk, if one doesn't have a plan, most likely will lose it all.

Monksdream

Monksdream 3 months ago

Quite often today’s hero is next day’s zero
Price is what you pay; value is what you get

dinogreeves

dinogreeves 3 months ago

Congrats on whoever scored here.

Monksdream

Monksdream 3 months ago

Runaway freight train
Reminds me of my TOP trade where I made 25x money

glenn1919

glenn1919 3 months ago

CADL.............................................a/h.........$$$$$$$$$$$$$$$$$$$$$$$$

philaya

philaya 3 months ago

Not selling ...
Insane luck calling.

GhosTraderX

GhosTraderX 3 months ago

Kaboom After Hours...

Hopped out at 10.00

Bought at 2.00 out at 10.00

Got a little lucky too...

GhosT

Candel Therapeutics

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions